Global Pediatric Drugs and Vaccines Market Overview
The global Pediatric Drugs and Vaccines market is expected to reach USD XX Million by the end of year 2027 from USD XX Million from the year 2021. In the span of last two years, Pediatric Drugs and Vaccines market has shown promising growth from both sides (Demand and Supply) and demand from end users is expected to rise continuously. It has also been observed that the Pediatric Drugs and Vaccines market has registered XX% of growth rate during 2016-2021 and is estimated to register XX% of CAGR during the period 2021 to 2027.
COVID 19 Impact on Pediatric Drugs and Vaccines Market
The COVID19 outbreak had a major impact on several industries on different levels; Some of these were border restrictions, transportation, and logistics restrictions, and worldwide bans. It also created economic uncertainty as the outbreak created a situation where both manufacturing and service industries were kept shut for very long period. Lack of availability of solution and the growing number of people infected with COVID and the uncertainty about the end of the crisis are much greater than with previous outbreaks. The pandemic has resulted in the closure of regions, border restrictions and the breakdown of transport networks.
Segment Analysis of Pediatric Drugs and Vaccines Market
This study on Pediatric Drugs and Vaccines market estimates and provides revenue growth at global, regional and country levels also, offers an overview of the latest developments in each of the sub-sectors from 2016 to 2027. For this analysis, READ Market Research has bifurcated the market of Pediatric Drugs and Vaccines into Type Segment, Application Segment and Regional Segment.
The companies mentioned in the report are:
Merck & Co. Inc. (USA)
Abbott Laboratories (USA)
Amgen Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)
Note: We can also add companies which are not part of the above list
One of the very important chapter of Pediatric Drugs and Vaccines market report is competitive analysis. In this chapter, we have presented a detailed overview of the competition and have provided the market revenue of each company along with the market share.
Global Pediatric Drugs and Vaccines Market Analysis By Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
In the year 2021, Diphtheria segment had XX% of market share and in terms of value, the Diphtheria market was valued at USD XX Million. It is expected that Diphtheria will have XX% of market share by the end of year 2027 and the incremental growth from 2021 till 2027 is expected to be USD XX Million.
Global Pediatric Drugs and Vaccines Market Analysis By Application
Newborn
Infant
Child
Newborn segment is expected to account for XX% of market share by the end of year 2027 from XX% in 2021. The Newborn segment is expected to grow at USD XX million by the end of year 2027.
Regional Analysis
Geographically, the global Pediatric Drugs and Vaccines market has been categorized as North America, Europe, the Asia-Pacific, the Middle East & Africa, and South America. North America accounted Pediatric Drugs and Vaccines market accounted for XX% of the market share in the year 2021 and register strong growth during the forecast period. However, the APAC area is experiencing significant growth due to various factors.
Report Scope:
Market Size: XX Million (Ask for Sample in order to view the details)
CAGR: XX% Ask for Sample in order to view the details)
Base Year: 2021
Forecast Period: 2022-2027
Forecast Units: Value (USD Million)
Geographies Covered: North America, Europe, Asia-Pacific, Middle East & Africa, South America
Frequently Asked Questions - FAQ:
What will be the dynamics for the adoption of Pediatric Drugs and Vaccines market based on Healthcare Industry
Which product will contribute more to the overall market share by 2027
Which region is expected to adopt Pediatric Drugs and Vaccines offerings at a fast rate
What are the key market dynamics influencing Pediatric Drugs and Vaccines market growth How will they turn into strengths or weaknesses of companies operating in the market space
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type (2022-2027)
1.3.2 Diphtheria
1.3.3 Influenza
1.3.4 Hepatitis
1.3.5 Pneumococcal Diseases
1.3.6 Meningococcal Diseases
1.3.7 Mumps
1.3.8 Others
1.4 Market Segment by Application
1.4.1 Global Pediatric Drugs and Vaccines Market Share by Application (2022-2027)
1.4.2 Newborn
1.4.3 Infant
1.4.4 Child
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Drugs and Vaccines Market Size
2.1.1 Global Pediatric Drugs and Vaccines Revenue 2016-2027
2.1.2 Global Pediatric Drugs and Vaccines Sales 2016-2027
2.2 Pediatric Drugs and Vaccines Growth Rate by Regions
2.2.1 Global Pediatric Drugs and Vaccines Sales by Regions 2016-2021
2.2.2 Global Pediatric Drugs and Vaccines Revenue by Regions 2016-2021
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Pediatric Drugs and Vaccines Sales by Manufacturers
3.1.1 Pediatric Drugs and Vaccines Sales by Manufacturers 2016-2021
3.1.2 Pediatric Drugs and Vaccines Sales Market Share by Manufacturers 2016-2021
3.2 Revenue by Manufacturers
3.2.1 Pediatric Drugs and Vaccines Revenue by Manufacturers (2016-2021)
3.2.2 Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.3 Global Pediatric Drugs and Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Pediatric Drugs and Vaccines Price by Manufacturers
3.4 Key Manufacturers Pediatric Drugs and Vaccines Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Pediatric Drugs and Vaccines Market
3.6 Key Manufacturers Pediatric Drugs and Vaccines Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Diphtheria Sales and Revenue (2016-2021)
4.1.2 Influenza Sales and Revenue (2016-2021)
4.1.3 Hepatitis Sales and Revenue (2016-2021)
4.1.4 Pneumococcal Diseases Sales and Revenue (2016-2021)
4.1.5 Meningococcal Diseases Sales and Revenue (2016-2021)
4.1.6 Mumps Sales and Revenue (2016-2021)
4.1.7 Others Sales and Revenue (2016-2021)
4.2 Global Pediatric Drugs and Vaccines Sales Market Share by Type
4.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Type
4.4 Pediatric Drugs and Vaccines Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Pediatric Drugs and Vaccines Sales by Application
6 United States
6.1 United States Pediatric Drugs and Vaccines Breakdown Data by Company
6.2 United States Pediatric Drugs and Vaccines Breakdown Data by Type
6.3 United States Pediatric Drugs and Vaccines Breakdown Data by Application
7 European Union
7.1 European Union Pediatric Drugs and Vaccines Breakdown Data by Company
7.2 European Union Pediatric Drugs and Vaccines Breakdown Data by Type
7.3 European Union Pediatric Drugs and Vaccines Breakdown Data by Application
8 China
8.1 China Pediatric Drugs and Vaccines Breakdown Data by Company
8.2 China Pediatric Drugs and Vaccines Breakdown Data by Type
8.3 China Pediatric Drugs and Vaccines Breakdown Data by Application
9 Rest of World
9.1 Rest of World Pediatric Drugs and Vaccines Breakdown Data by Company
9.2 Rest of World Pediatric Drugs and Vaccines Breakdown Data by Type
9.3 Rest of World Pediatric Drugs and Vaccines Breakdown Data by Application
9.4 Rest of World Pediatric Drugs and Vaccines Breakdown Data by Countries
9.4.1 Rest of World Pediatric Drugs and Vaccines Sales by Countries
9.4.2 Rest of World Pediatric Drugs and Vaccines Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Merck & Co., Inc. (USA)
10.1.1 Merck & Co., Inc. (USA) Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
10.1.4 Pediatric Drugs and Vaccines Product Introduction
10.1.5 Merck & Co., Inc. (USA) Recent Development
10.2 Abbott Laboratories (USA)
10.2.1 Abbott Laboratories (USA) Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
10.2.4 Pediatric Drugs and Vaccines Product Introduction
10.2.5 Abbott Laboratories (USA) Recent Development
10.3 Amgen, Inc. (USA)
10.3.1 Amgen, Inc. (USA) Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
10.3.4 Pediatric Drugs and Vaccines Product Introduction
10.3.5 Amgen, Inc. (USA) Recent Development
10.4 Eli Lilly and Company (USA)
10.4.1 Eli Lilly and Company (USA) Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
10.4.4 Pediatric Drugs and Vaccines Product Introduction
10.4.5 Eli Lilly and Company (USA) Recent Development
10.5 F. Hoffmann-La Roche Ltd (Switzerland)
10.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
10.5.4 Pediatric Drugs and Vaccines Product Introduction
10.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
10.6 Genentech, Inc. (USA)
10.6.1 Genentech, Inc. (USA) Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
10.6.4 Pediatric Drugs and Vaccines Product Introduction
10.6.5 Genentech, Inc. (USA) Recent Development
10.7 GlaxoSmithKline plc. (UK)
10.7.1 GlaxoSmithKline plc. (UK) Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
10.7.4 Pediatric Drugs and Vaccines Product Introduction
10.7.5 GlaxoSmithKline plc. (UK) Recent Development
10.8 Janssen Biologics B.V. (USA)
10.8.1 Janssen Biologics B.V. (USA) Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
10.8.4 Pediatric Drugs and Vaccines Product Introduction
10.8.5 Janssen Biologics B.V. (USA) Recent Development
10.9 Actelion Pharmaceuticals
10.9.1 Actelion Pharmaceuticals Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
10.9.4 Pediatric Drugs and Vaccines Product Introduction
10.9.5 Actelion Pharmaceuticals Recent Development
10.10 AstraZeneca Plc. (UK)
10.10.1 AstraZeneca Plc. (UK) Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Pediatric Drugs and Vaccines
10.10.4 Pediatric Drugs and Vaccines Product Introduction
10.10.5 AstraZeneca Plc. (UK) Recent Development
10.11 Boehringer Ingelheim GmbH (Germany)
10.12 Bristol-Myers Squibb Company (USA)
10.13 Allergan, Inc. (USA)
10.14 Novartis AG (Switzerland)
10.15 Novo Nordisk A/S (Denmark)
10.16 Pfizer, Inc. (USA)
10.17 Sanofi S.A (France)
10.18 Shionogi Inc. (USA)
10.19 Shire Pharmaceuticals Group Plc. (UK)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Pediatric Drugs and Vaccines Sales Channels
11.2.2 Pediatric Drugs and Vaccines Distributors
11.3 Pediatric Drugs and Vaccines Customers
12 Market Forecast
12.1 Global Pediatric Drugs and Vaccines Sales and Revenue Forecast 2022-2027
12.2 Global Pediatric Drugs and Vaccines Sales Forecast by Type
12.3 Global Pediatric Drugs and Vaccines Sales Forecast by Application
12.4 Pediatric Drugs and Vaccines Forecast by Regions
12.4.1 Global Pediatric Drugs and Vaccines Sales Forecast by Regions 2022-2027
12.4.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Regions 2022-2027
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Disclaimer
List of Tables and Figures
Figure Pediatric Drugs and Vaccines Product Picture
Table Pediatric Drugs and Vaccines Key Market Segments
Table Major Manufacturers Pediatric Drugs and Vaccines Covered in This Report
Table Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type 2022-2027 (MT) & (Million US$)
Figure Global Pediatric Drugs and Vaccines Sales Market Shar by Type 2016-2027
Figure Diphtheria Figures
Table Major Manufacturers of Diphtheria
Figure Influenza Figures
Table Major Manufacturers of Influenza
Figure Hepatitis Figures
Table Major Manufacturers of Hepatitis
Figure Pneumococcal Diseases Figures
Table Major Manufacturers of Pneumococcal Diseases
Figure Meningococcal Diseases Figures
Table Major Manufacturers of Meningococcal Diseases
Figure Mumps Figures
Table Major Manufacturers of Mumps
Figure Others Figures
Table Major Manufacturers of Others
Table Global Pediatric Drugs and Vaccines Market Share by Application 2022-2027 (MT)
Figure Newborn Use Case
Figure Infant Use Case
Figure Child Use Case
Figure Pediatric Drugs and Vaccines Report Years Considered
Figure Global Pediatric Drugs and Vaccines Market Size 2016-2027 (Million US$)
Figure Global Pediatric Drugs and Vaccines Sales 2016-2021 (MT)
Table Global Pediatric Drugs and Vaccines Market Size by Regions 2016-2021 (MT) & (Million US$)
Table Global Pediatric Drugs and Vaccines Sales by Regions 2016-2021 (MT)
Table Global Pediatric Drugs and Vaccines Sales Market Share by Regions 2016-2021
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Regions 2016-2021
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Regions in 2021
Table Global Pediatric Drugs and Vaccines Revenue by Regions 2016-2021 (Million US$)
Table Global Pediatric Drugs and Vaccines Revenue Market Share by Regions 2016-2021
Figure Global Pediatric Drugs and Vaccines Revenue Market Share by Regions 2016-2021
Figure Global Pediatric Drugs and Vaccines Revenue Market Share by Regions in 2021
Table Market Top Trends
Table Global Pediatric Drugs and Vaccines Sales by Manufacturers (2016-2021) (MT)
Table Global Pediatric Drugs and Vaccines Sales Share by Manufacturers (2016-2021)
Figure Global Pediatric Drugs and Vaccines Sales Share by Manufacturers in 2021
Table Pediatric Drugs and Vaccines Revenue by Manufacturers (2016-2021) (Million USD)
Table Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2016-2021)
Figure Pediatric Drugs and Vaccines Value Share by Manufacturers in 2021
Table Global Pediatric Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Pediatric Drugs and Vaccines Price (2016-2021) (USD/Kg)
Table Key Manufacturers Pediatric Drugs and Vaccines Plants/Factories Distribution
Table Key Manufacturers Pediatric Drugs and Vaccines Area Served
Table Date of Key Manufacturers Enter into Pediatric Drugs and Vaccines Market
Table Key Manufacturers Pediatric Drugs and Vaccines Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Diphtheria Sales and Revenue (2016-2021) (MT) & (Million US$)
Table Global Influenza Sales and Revenue (2016-2021) (MT) & (Million US$)
Table Global Hepatitis Sales and Revenue (2016-2021) (MT) & (Million US$)
Table Global Pneumococcal Diseases Sales and Revenue (2016-2021) (MT) & (Million US$)
Table Global Meningococcal Diseases Sales and Revenue (2016-2021) (MT) & (Million US$)
Table Global Mumps Sales and Revenue (2016-2021) (MT) & (Million US$)
Table Global Others Sales and Revenue (2016-2021) (MT) & (Million US$)
Table Global Pediatric Drugs and Vaccines Sales by Type (2016-2021) (MT)
Table Global Pediatric Drugs and Vaccines Sales Share by Type (2016-2021)
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Type in 2021
Table Global Pediatric Drugs and Vaccines Revenue by Type (2016-2021) (Million US$)
Table Global Pediatric Drugs and Vaccines Revenue Share by Type (2016-2021)
Figure Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)
Figure Global Pediatric Drugs and Vaccines Revenue Market Share by Type in 2021
Table Pediatric Drugs and Vaccines Price by Type 2016-2021 (USD/Kg)
Table Global Pediatric Drugs and Vaccines Sales by Application (2016-2021) (MT)
Table Global Pediatric Drugs and Vaccines Sales Share by Application (2016-2021)
Figure Global Sales Pediatric Drugs and Vaccines Market Share by Application (2016-2021)
Figure Global Sales Pediatric Drugs and Vaccines Market Share by Application (2016-2021)
Figure United States Pediatric Drugs and Vaccines Sales Growth Rate 2016-2021 (MT)
Figure United States Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Table United States Pediatric Drugs and Vaccines Sales by Company (2016-2021) (MT)
Table United States Pediatric Drugs and Vaccines Sales Market Share by Company (2016-2021)
Figure United States Pediatric Drugs and Vaccines Sales Market Share by Company in 2021
Table United States Pediatric Drugs and Vaccines Sales by Type (2016-2021) (MT)
Table United States Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Figure United States Pediatric Drugs and Vaccines Market Share by Type in 2021
Table United States Pediatric Drugs and Vaccines Sales by Application (2016-2021) (MT)
Table United States Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Figure United States Pediatric Drugs and Vaccines Market Share by Application in 2021
Figure European Union Pediatric Drugs and Vaccines Sales Growth Rate 2016-2021 (MT)
Figure European Union Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Table European Union Pediatric Drugs and Vaccines Sales by Company (2016-2021) (MT)
Table European Union Pediatric Drugs and Vaccines Sales Market Share by Company (2016-2021)
Figure European Union Pediatric Drugs and Vaccines Sales Market Share by Company in 2021
Table European Union Pediatric Drugs and Vaccines Sales by Type (2016-2021) (MT)
Table European Union Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Figure European Union Pediatric Drugs and Vaccines Market Share by Type
Table European Union Pediatric Drugs and Vaccines Sales by Application (2016-2021) (MT)
Table European Union Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Figure European Union Pediatric Drugs and Vaccines Market Share by Application
Figure China Pediatric Drugs and Vaccines Sales Growth Rate 2016-2021 (MT)
Figure China Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Table China Pediatric Drugs and Vaccines Sales by Company (2016-2021) (MT)
Table China Pediatric Drugs and Vaccines Sales Market Share by Company (2016-2021)
Figure China Pediatric Drugs and Vaccines Sales Market Share by Company in 2021
Table China Pediatric Drugs and Vaccines Sales by Type (2016-2021) (MT)
Table China Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Figure China Pediatric Drugs and Vaccines Market Share by Type in 2021
Table China Pediatric Drugs and Vaccines Sales by Application (2016-2021) (MT)
Table China Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Figure China Pediatric Drugs and Vaccines Market Share by Application in 2021
Figure Rest of World Pediatric Drugs and Vaccines Sales Growth Rate 2016-2021 (MT)
Figure Rest of World Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2021 (Million US$)
Table Rest of World Pediatric Drugs and Vaccines Sales by Company (2016-2021) (MT)
Table Rest of World Pediatric Drugs and Vaccines Sales Market Share by Company (2016-2021)
Figure Rest of World Pediatric Drugs and Vaccines Sales Market Share by Company in 2021
Table Rest of World Pediatric Drugs and Vaccines Sales by Type (2016-2021) (MT)
Table Rest of World Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
Figure Rest of World Pediatric Drugs and Vaccines Market Share by Type in 2021
Table Rest of World Pediatric Drugs and Vaccines Sales by Application (2016-2021) (MT)
Table Rest of World Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
Figure Rest of World Pediatric Drugs and Vaccines Market Share by Application in 2021
Table Rest of World Pediatric Drugs and Vaccines Sales by Countries (2016-2021) (MT)
Table Rest of World Pediatric Drugs and Vaccines Sales Market Share by Countries (2016-2021)
Figure Rest of World Pediatric Drugs and Vaccines Sales Market Share by Countries in 2021
Table Rest of World Pediatric Drugs and Vaccines Revenue by Countries (2016-2021) (Million US$)
Table Rest of World Pediatric Drugs and Vaccines Revenue Market Share by Countries (2016-2021)
Figure Rest of World Pediatric Drugs and Vaccines Revenue Market Share by Countries in 2021
Figure Japan Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure Japan Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (MT)
Figure Korea Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure Korea Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (MT)
Figure India Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure India Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (MT)
Figure Southeast Asia Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021) (MT)
Figure Southeast Asia Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2021) (MT)
Table Merck & Co., Inc. (USA) Company Details
Table Merck & Co., Inc. (USA) Description and Business Overview
Table Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021)
Table Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales Market Share in Global Market
Table Merck & Co., Inc. (USA) Recent Development
Table Abbott Laboratories (USA) Company Details
Table Abbott Laboratories (USA) Description and Business Overview
Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021)
Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales Market Share in Global Market
Table Abbott Laboratories (USA) Recent Development
Table Amgen, Inc. (USA) Company Details
Table Amgen, Inc. (USA) Description and Business Overview
Table Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021)
Table Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales Market Share in Global Market
Table Amgen, Inc. (USA) Recent Development
Table Eli Lilly and Company (USA) Company Details
Table Eli Lilly and Company (USA) Description and Business Overview
Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021)
Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales Market Share in Global Market
Table Eli Lilly and Company (USA) Recent Development
Table F. Hoffmann-La Roche Ltd (Switzerland) Company Details
Table F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
Table F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021)
Table F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales Market Share in Global Market
Table F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
Table Genentech, Inc. (USA) Company Details
Table Genentech, Inc. (USA) Description and Business Overview
Table Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021)
Table Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales Market Share in Global Market
Table Genentech, Inc. (USA) Recent Development
Table GlaxoSmithKline plc. (UK) Company Details
Table GlaxoSmithKline plc. (UK) Description and Business Overview
Table GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021)
Table GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales Market Share in Global Market
Table GlaxoSmithKline plc. (UK) Recent Development
Table Janssen Biologics B.V. (USA) Company Details
Table Janssen Biologics B.V. (USA) Description and Business Overview
Table Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021)
Table Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales Market Share in Global Market
Table Janssen Biologics B.V. (USA) Recent Development
Table Actelion Pharmaceuticals Company Details
Table Actelion Pharmaceuticals Description and Business Overview
Table Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021)
Table Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales Market Share in Global Market
Table Actelion Pharmaceuticals Recent Development
Table AstraZeneca Plc. (UK) Company Details
Table AstraZeneca Plc. (UK) Description and Business Overview
Table AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales Growth Rate (2016-2021)
Table AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales Market Share in Global Market
Table AstraZeneca Plc. (UK) Recent Development
Table Boehringer Ingelheim GmbH (Germany) Company Details
Table Bristol-Myers Squibb Company (USA) Company Details
Table Allergan, Inc. (USA) Company Details
Table Novartis AG (Switzerland) Company Details
Table Novo Nordisk A/S (Denmark) Company Details
Table Pfizer, Inc. (USA) Company Details
Table Sanofi S.A (France) Company Details
Table Shionogi Inc. (USA) Company Details
Table Shire Pharmaceuticals Group Plc. (UK) Company Details
Figure Pediatric Drugs and Vaccines Value Chain
Table Pediatric Drugs and Vaccines Distributors List
Table Pediatric Drugs and Vaccines Customers List
Table Global Pediatric Drugs and Vaccines Sales Forecast 2022-2027 (MT) & (Million US$)
Figure Global Pediatric Drugs and Vaccines Sales Forecast 2022-2027 (MT)
Figure Global Pediatric Drugs and Vaccines Revenue Forecast 2022-2027 (Million US$)
Table Global Pediatric Drugs and Vaccines Sales Forecast by Type 2022-2027 (MT)
Figure Global Pediatric Drugs and Vaccines Sales Forecast by Type 2022-2027 (MT)
Figure Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Type 2022-2027
Table Global Pediatric Drugs and Vaccines Sales Forecast by Application 2022-2027 (MT)
Figure Global Pediatric Drugs and Vaccines Sales Forecast by Application 2022-2027 (MT)
Figure Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Application 2022-2027
Table Global Pediatric Drugs and Vaccines Sales Forecast by Regions 2022-2027 (MT)
Figure Global Pediatric Drugs and Vaccines Sales Forecast by Regions 2022-2027 (MT)
Figure Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Regions 2022-2027
Table Global Pediatric Drugs and Vaccines Revenue Forecast by Regions 2022-2027 (MT)
Figure Global Pediatric Drugs and Vaccines Revenue Forecast by Regions 2022-2027 (MT)
Figure Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Regions 2022-2027
Figure United States Pediatric Drugs and Vaccines Sales Forecast 2022-2027 (MT)
Figure United States Pediatric Drugs and Vaccines Revenue Forecast 2022-2027 (Million US$)
Figure European Union Pediatric Drugs and Vaccines Sales Forecast 2022-2027 (MT)
Figure European Union Pediatric Drugs and Vaccines Revenue Forecast 2022-2027 (Million US$)
Figure China Pediatric Drugs and Vaccines Sales Forecast 2022-2027 (MT)
Figure China Pediatric Drugs and Vaccines Revenue Forecast 2022-2027 (Million US$)
Figure Japan Pediatric Drugs and Vaccines Sales Forecast 2022-2027 (MT)
Figure Japan Pediatric Drugs and Vaccines Revenue Forecast 2022-2027 (Million US$)
Figure Korea Pediatric Drugs and Vaccines Sales Forecast 2022-2027 (MT)
Figure Korea Pediatric Drugs and Vaccines Revenue Forecast 2022-2027 (Million US$)
Figure India Pediatric Drugs and Vaccines Sales Forecast 2022-2027 (MT)
Figure India Pediatric Drugs and Vaccines Revenue Forecast 2022-2027 (Million US$)
Figure Southeast Asia Pediatric Drugs and Vaccines Sales Forecast 2022-2027 (MT)
Figure Southeast Asia Pediatric Drugs and Vaccines Revenue Forecast 2022-2027 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources